Reviewing CVS Health (NYSE:CVS) and Hims & Hers Health (NYSE:HIMS)

CVS Health (NYSE:CVS – Get Free Report) and Hims & Hers Health (NYSE:HIMS – Get Free Report) are both healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, dividends, valuation, profitability, risk, earnings and institutional ownership.

Insider & Institutional Ownership

80.7% of CVS Health shares are held by institutional investors. Comparatively, 63.5% of Hims & Hers Health shares are held by institutional investors. 0.9% of CVS Health shares are held by insiders. Comparatively, 11.8% of Hims & Hers Health shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Volatility & Risk

CVS Health has a beta of 0.58, indicating that its share price is 42% less volatile than the S&P 500. Comparatively, Hims & Hers Health has a beta of 2.53, indicating that its share price is 153% more volatile than the S&P 500.

Earnings & Valuation

This table compares CVS Health and Hims & Hers Health”s revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
CVS Health $402.07 billion 0.25 $1.77 billion $8.59 9.32
Hims & Hers Health $2.35 billion 1.60 $128.37 million ($0.83) -19.30

CVS Health has higher revenue and earnings than Hims & Hers Health. Hims & Hers Health is trading at a lower price-to-earnings ratio than CVS Health, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares CVS Health and Hims & Hers Health’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
CVS Health 2.62% 13.65% 4.20%
Hims & Hers Health -6.65% -9.62% -1.38%

Analyst Recommendations

This is a summary of recent recommendations and price targets for CVS Health and Hims & Hers Health, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
CVS Health 0 2 23 0 2.92
Hims & Hers Health 1 12 3 0 2.12

CVS Health presently has a consensus target price of $107.33, suggesting a potential upside of 34.02%. Hims & Hers Health has a consensus target price of $31.53, suggesting a potential upside of 96.84%. Given Hims & Hers Health’s higher possible upside, analysts clearly believe Hims & Hers Health is more favorable than CVS Health.

Summary

CVS Health beats Hims & Hers Health on 10 of the 14 factors compared between the two stocks.

About CVS Health

(Get Free Report)

CVS Health is a U.S.-based health care company that operates retail pharmacies, provides pharmacy benefit management services, and offers health insurance and other health services. Its businesses include CVS Pharmacy, pharmacy benefit manager CVS Caremark, and Aetna, its health benefits division. The company also provides care through MinuteClinic walk-in clinics and health care businesses including Oak Street Health and Signify Health. Its services span prescription fulfillment, pharmacy benefit management, health insurance, primary care, and in-home and community-based care.

About Hims & Hers Health

(Get Free Report)

Hims & Hers Health, Inc. operates a consumer-focused telehealth platform that connects patients with licensed healthcare providers and offers access to treatments and wellness products. Its services include online consultations, prescription care and over-the-counter products. The company serves a range of health needs, including hair loss, sexual health, skin care, mental health and weight management. Its platform also offers primary care and other services, with offerings varying by location and individual eligibility.

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.